Marly Didizian

Marly specialises in commercial and regulatory IT, outsourcing, data protection, media and broadcasting and telecoms. Marly’s broad practice experience as a specialist allows her to provide comprehensive, all-round advice on her transactions.

Work highlights

Marly’s experience includes advising:

• Takeda: advising on the disposal of its global respiratory product portfolio to Astra Zeneca and its haemostasis product TachoSil to J&J.
• Novartis: advising on its global asset swap with GSK and subsequent disposal of the flu vaccines business to CSL; and on its recent acquisition of Aspen Pharma in Japan.
• Arqiva: advising on the carve out sale of its telecoms division (towers business) to Cellnex Telecom S.A. for £2bn. 
• Nestlé: advising on the sale of its global skincare division, Galderma; and on its 50:50 joint venture with PAI to merge Nestlé's ice cream and frozen food business with R&R Ice Cream.
• BP: advising on a range of deals including its US$1.5bn outsourcing of application development and application management services.
• Accord: advising on their successful bid for Allergan Plc's former pharma generics business from Teva.

Marly studied law at University of Cambridge, Robinson College, and College of Law in London.

She is also fluent in Arabic, Armenian, English, French